Shun-Ichi Kimura, Shunto Kawamura, Takashi Toya, Keiji Okinaka, Hiroki Hosoi, Naoyuki Uchida, Noriko Doki, Tetsuya Nishida, Masatsugu Tanaka, Yuta Hasegawa, et al. Letermovir Prophylaxis and Risk of Bacterial or Fungal Infection after Allogeneic Hematopoietic Cell Transplantation. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025. 102888-102888
Yasutaka Sadaga, Yuho Najima, Takayoshi Tachibana, Kaito Harada, Takuya Miyazaki, Takashi Toya, Masatsugu Tanaka, Yukiko Misaki, Hiroki Yokoyama, Shinichiro Fujiwara, et al. Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival After Second Allogeneic Stem Cell Transplantation. Transplantation and cellular therapy. 2025
Yasutaka Sadaga, Daisuke Watanabe, Yuho Najima, Daichi Sadato, Chizuko Hirama, Kana Kato, Kaori Kondo, Chika Kato, Satoshi Sakai, Yasuhiro Kambara, et al. Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation. Hematology (Amsterdam, Netherlands). 2025. 30. 1. 2539550-2539550
Kairi Kojo, Daichi Sadato, Takashi Toya, Keisuke Oboki, Chizuko Hirama, Yasumasa Nishito, Chika Kato, Hiroaki Shimizu, Kyoko Haraguchi, Hironori Harada, et al. NGS-based quantitative typing to identify HLA loss relapse after allogeneic stem cell transplantation. Leukemia research. 2025. 160. 108135-108135
Yasutaka Masuda, Takashi Toya, Riki Yamakawa, Kairi Kojo, Kana Kato, Yasutaka Sadaga, Kaori Kondo, Chika Kato, Hiroki Hatsusawa, Fumihiko Ouchi, et al. Realworld Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients. Transplant Infectious Disease. 2025. e70116